raloxifene hydrochloride has been researched along with phytoestrogens in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (11.11) | 18.2507 |
| 2000's | 17 (62.96) | 29.6817 |
| 2010's | 6 (22.22) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Fitzpatrick, LA | 1 |
| Evans, A; Healy, D; Vollenhoven, B | 1 |
| Carolin, KA; Pass, HA | 1 |
| Halbreich, U; Kahn, LS | 1 |
| Blumenthal, R; Bush, TL; Clarkson, TB; Lobo, R | 1 |
| Diel, P; Michna, H; Olff, S; Schmidt, S | 1 |
| Knoll, E; Kohen, F; Somjen, D; Stern, N | 1 |
| Duvernoy, CS; Mosca, L | 1 |
| Clarkson, TB; Mikkola, TS | 1 |
| Grümmer, R; Heikaus, S; Traub, O; Winterhager, E | 1 |
| Romero, M | 1 |
| Somjen, D; Yoles, I | 1 |
| Bonn, D | 1 |
| László, A | 1 |
| Somjen, D | 1 |
| Gayer, B; Katzburg, S; Kohen, F; Livne, E; Somjen, D | 1 |
| Castrellon, AB; Glück, S | 1 |
| Altavilla, D; Antoci, S; Armbruster, MA; Bitto, A; Burnett, BP; Di Stefano, V; Granese, R; Irrera, N; Levy, RM; Marini, H; Minutoli, L; Polito, F; Squadrito, F | 1 |
| Cegieła, U; Folwarczna, J; Kaczmarczyk-Sedlak, I; Nowińska, B; Pytlik, M; Sliwiński, L; Trzeciak, H; Trzeciak, HI | 1 |
| Gayer, B; Katzburg, S; Kohen, F; Livne, E; Posner, GH; Somjen, D; Yoles, I | 1 |
| Adamo, EB; Altavilla, D; Bitto, A; Calò, M; Irrera, N; Marini, H; Minutoli, L; Polito, F; Squadrito, F; Vaccaro, M | 1 |
| Grafi-Cohen, M; Katzburg, S; Knoll, E; Sharon, O; Somjen, D; Stern, N | 1 |
| Adamo, EB; Altavilla, D; Bitto, A; Irrera, N; Marini, H; Micali, A; Minutoli, L; Polito, F; Squadrito, F; Vaccaro, M | 1 |
| Kim, JH; Kim, YJ | 1 |
| González-Rodríguez, A; Seeman, MV | 1 |
| Dor, RRB; Guerrieri, GM; Harsh, VL; Li, HJ; Martinez, PE; Nieman, LK; Palladino, PP; Rubinow, DR; Schmidt, PJ; Wakim, P; Wei, SM | 1 |
12 review(s) available for raloxifene hydrochloride and phytoestrogens
| Article | Year |
|---|---|
Selective estrogen receptor modulators and phytoestrogens: new therapies for the postmenopausal women.
Topics: Aged; Bone Density; Estrogen Antagonists; Estrogen Replacement Therapy; Estrogens; Estrogens, Non-Steroidal; Female; Humans; Isoflavones; Middle Aged; Osteoporosis, Postmenopausal; Phytoestrogens; Piperidines; Plant Preparations; Postmenopause; Raloxifene Hydrochloride; Receptors, Estrogen; Tamoxifen | 1999 |
Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 6: Executive summary and consensus statement. Proceedings of a conference held at Boar's Head Inn, Charlottesville, Virginia, September 21-23, 1997.
Topics: Breast Neoplasms; Cardiovascular Diseases; Clinical Trials as Topic; Estrogen Antagonists; Estrogens; Estrogens, Non-Steroidal; Female; Humans; Isoflavones; Menopause; Osteoporosis; Phytoestrogens; Piperidines; Plant Preparations; Raloxifene Hydrochloride; Receptors, Estrogen; Survivors | 1999 |
Modern antioestrogens and the coming revolution in women's health care.
Topics: Bone and Bones; Breast Neoplasms; Clomiphene; Estradiol; Estrogen Receptor Modulators; Estrogens, Non-Steroidal; Female; Fulvestrant; Genital Diseases, Female; Humans; Isoflavones; Osteoporosis; Phytoestrogens; Plant Preparations; Plants; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Women's Health | 1999 |
Prevention of breast cancer.
Topics: Adult; Aged; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Biological Products; Breast Neoplasms; Breast Neoplasms, Male; Carotenoids; Cathepsin D; Cell Adhesion Molecules; Cell Cycle; Clinical Trials, Phase III as Topic; Drug Screening Assays, Antitumor; Estrogens, Non-Steroidal; Female; Fenretinide; Genetic Predisposition to Disease; Hormone Antagonists; Humans; Isoflavones; Male; Mammary Neoplasms, Experimental; Mastectomy; Mice; Middle Aged; Neovascularization, Pathologic; Ovariectomy; Phytoestrogens; Plant Preparations; Raloxifene Hydrochloride; Rats; Retinoids; Risk Assessment; Risk Factors; Selenium; Tamoxifen; Terpenes | 2000 |
Selective oestrogen receptor modulators--current and future brain and behaviour applications.
Topics: Behavior; Brain; Central Nervous System; Clinical Trials as Topic; Estrogens; Estrogens, Non-Steroidal; Female; Humans; Isoflavones; Male; Phytoestrogens; Plant Preparations; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators | 2000 |
SERMs and cardiovascular disease in women. How do these agents affect risk?
Topics: Blood Coagulation Factors; Cardiovascular Diseases; Estrogens, Non-Steroidal; Female; Glycine max; Humans; Isoflavones; Lipid Metabolism; Phytoestrogens; Plant Preparations; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen | 2001 |
Estrogen replacement therapy, atherosclerosis, and vascular function.
Topics: Aged; Aging; Animals; Coronary Artery Disease; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens, Non-Steroidal; Female; Humans; Inflammation; Isoflavones; Lipids; Macaca; Male; Middle Aged; Models, Animal; Phytoestrogens; Plant Preparations; Progestins; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2002 |
Bioidentical hormone replacement therapy. Customizing care for perimenopausal and menopausal women.
Topics: Chemistry, Pharmaceutical; Climacteric; Drug Combinations; Drug Compounding; Drug Monitoring; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrogens, Non-Steroidal; Female; Humans; Isoflavones; Medroxyprogesterone Acetate; Menopause; Osteoporosis, Postmenopausal; Patient Care Planning; Phytoestrogens; Plant Preparations; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators | 2002 |
[Postmenopausal osteoporosis].
Topics: Absorptiometry, Photon; Anabolic Agents; Calcitonin; Calcium, Dietary; Diphosphonates; Estrogen Replacement Therapy; Female; Fractures, Bone; Humans; Isoflavones; Motor Activity; Norpregnenes; Osteoporosis, Postmenopausal; Phytoestrogens; Plant Preparations; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Vitamin D; Weight-Bearing | 2004 |
Vitamin D modulation of the activity of estrogenic compounds in bone cells in vitro and in vivo.
Topics: Animals; Bone and Bones; Calcitriol; Creatine Kinase; Dihydrotestosterone; Drug Interactions; Estradiol; Estrogens; Female; Humans; In Vitro Techniques; Male; Ovariectomy; Phytoestrogens; Raloxifene Hydrochloride; Rats; Rats, Wistar; Receptors, Estrogen; RNA, Messenger; Selective Estrogen Receptor Modulators; Vitamin D | 2007 |
Chemoprevention of breast cancer.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aromatase Inhibitors; Breast Neoplasms; Carotenoids; Chemoprevention; Female; Gonadotropin-Releasing Hormone; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Phytoestrogens; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen | 2008 |
Pharmacotherapy for schizophrenia in postmenopausal women.
Topics: Antipsychotic Agents; Female; Humans; Phytoestrogens; Postmenopause; Raloxifene Hydrochloride; Receptors, Estrogen; Schizophrenia; Venous Thromboembolism | 2018 |
1 trial(s) available for raloxifene hydrochloride and phytoestrogens
| Article | Year |
|---|---|
The short-term effects of estradiol, raloxifene, and a phytoestrogen in women with perimenopausal depression.
Topics: Depression; Double-Blind Method; Estradiol; Estrogens; Female; Humans; Perimenopause; Phytoestrogens; Raloxifene Hydrochloride; Treatment Outcome | 2021 |
14 other study(ies) available for raloxifene hydrochloride and phytoestrogens
| Article | Year |
|---|---|
Molecular identification of potential selective estrogen receptor modulator (SERM) like properties of phytoestrogens in the human breast cancer cell line MCF-7.
Topics: Blotting, Western; Breast; Coumestrol; Diet; Estradiol; Estrogen Antagonists; Estrogens, Non-Steroidal; Fulvestrant; Genistein; Humans; Isoflavones; Molecular Structure; Phytoestrogens; Plant Preparations; Raloxifene Hydrochloride; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Selective Estrogen Receptor Modulators; Tumor Cells, Cultured | 2001 |
Effects of phytoestrogens on DNA synthesis and creatine kinase activity in vascular cells.
Topics: Animals; Aorta; Cells, Cultured; Chromans; Creatine Kinase; Creatine Kinase, MB Form; DNA; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Equol; Estrogen Antagonists; Estrogens, Non-Steroidal; Female; Genistein; Humans; Isoenzymes; Isoflavones; Muscle, Smooth, Vascular; Phytoestrogens; Plant Preparations; Quercetin; Raloxifene Hydrochloride; Rats; Rats, Wistar; Thymidine; Tritium; Umbilical Arteries | 2001 |
Hormone replacement therapy trials: an update.
Topics: Coronary Disease; Estrogen Replacement Therapy; Estrogens, Non-Steroidal; Female; Humans; Isoflavones; Middle Aged; Phytoestrogens; Plant Preparations; Postmenopause; Primary Prevention; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen | 2002 |
Responsiveness of endometrial genes Connexin26, Connexin43, C3 and clusterin to primary estrogen, selective estrogen receptor modulators, phyto- and xenoestrogens.
Topics: Animals; Clusterin; Complement C3; Connexin 26; Connexin 43; Connexins; Diethylstilbestrol; Endometrium; Estrogens; Estrogens, Non-Steroidal; Female; Gene Expression Regulation; Glycoproteins; Isoflavones; Molecular Chaperones; Phytoestrogens; Plant Preparations; Polychlorinated Biphenyls; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Tamoxifen | 2002 |
DT56a (Tofupill/Femarelle) selectively stimulates creatine kinase specific activity in skeletal tissues of rats but not in the uterus.
Topics: Animals; Bone and Bones; Cartilage; Creatine Kinase; Diaphyses; Estradiol; Estrogens, Non-Steroidal; Female; Glycine max; Isoenzymes; Isoflavones; Phytoestrogens; Plant Extracts; Plant Preparations; Raloxifene Hydrochloride; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators; Uterus | 2003 |
New ways with old bones. Osteoporosis researchers look for drugs to replace hormone replacement therapy.
Topics: Antioxidants; Bone Resorption; Carrier Proteins; Contraindications; Female; Hormone Replacement Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isoflavones; Leptin; Membrane Glycoproteins; Osteoporosis; Phytoestrogens; Plant Preparations; Raloxifene Hydrochloride; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Selective Estrogen Receptor Modulators; Teriparatide | 2004 |
Daidzein but not other phytoestrogens preserves bone architecture in ovariectomized female rats in vivo.
Topics: Adipocytes; Animals; Bone and Bones; Bone Marrow; Creatine Kinase; Estradiol; Female; Genistein; Growth Plate; Isoflavones; Ovariectomy; Phytoestrogens; Raloxifene Hydrochloride; Rats; Rats, Wistar; Tibia; Trabecular Meshwork | 2008 |
Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol.
Topics: Alendronate; Animals; Bone Density; Bone Density Conservation Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Female; Genistein; Osteoporosis; Ovariectomy; Phytoestrogens; Raloxifene Hydrochloride; Random Allocation; Rats; Rats, Sprague-Dawley; Time Factors | 2008 |
A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system.
Topics: Animals; Body Weight; Bone and Bones; Bone Density; Bone Marrow Cells; Bone Resorption; Calcification, Physiologic; Calcium; Cell Count; Cells, Cultured; Disease Models, Animal; Drug Combinations; Estradiol; Estriol; Female; Gene Expression; Genistein; Humans; Mice; Mice, Inbred BALB C; Organ Size; Osteoblasts; Osteoclasts; Osteoporosis, Postmenopausal; Ovariectomy; Phytoestrogens; Raloxifene Hydrochloride; Rats; Rats, Wistar; RNA, Messenger; Selective Estrogen Receptor Modulators; Thymus Gland; Uterus | 2009 |
The effects of native and synthetic estrogenic compounds as well as vitamin D less-calcemic analogs on adipocytes content in rat bone marrow.
Topics: Adipocytes; Animals; Bone Marrow Cells; Calcitriol; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Genistein; Isoflavones; Ovariectomy; Phytoestrogens; Raloxifene Hydrochloride; Rats; Rats, Wistar | 2011 |
Genistein aglycone improves skin repair in an incisional model of wound healing: a comparison with raloxifene and oestradiol in ovariectomized rats.
Topics: Animals; Dermatologic Surgical Procedures; Disease Models, Animal; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Genistein; GTP-Binding Proteins; Ovariectomy; Phytoestrogens; Protein Glutamine gamma Glutamyltransferase 2; Raloxifene Hydrochloride; Random Allocation; Rats; Rats, Sprague-Dawley; Skin; Tensile Strength; Transforming Growth Factor beta1; Transglutaminases; Vascular Endothelial Growth Factor A; Wound Healing | 2010 |
The effects of estrogen receptors α- and β-specific agonists and antagonists on cell proliferation and energy metabolism in human bone cell line.
Topics: Bone and Bones; Cell Line; Cell Proliferation; Chromatography, High Pressure Liquid; Energy Metabolism; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Genistein; Humans; Hydroxyeicosatetraenoic Acids; Nitriles; Phytoestrogens; Pyrazoles; Raloxifene Hydrochloride; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Genistein aglycone, a soy-derived isoflavone, improves skin changes induced by ovariectomy in rats.
Topics: Animals; Ethinyl Estradiol; Female; Genistein; Glycine max; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Models, Animal; Ovariectomy; Phytoestrogens; Postmenopause; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Skin Aging; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2012 |
Effects of genistein in combination with conjugated estrogens on endometrial hyperplasia and metabolic dysfunction in ovariectomized mice.
Topics: Adiposity; Animals; Diet, High-Fat; Dietary Supplements; Endometrial Hyperplasia; Endometrium; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Genistein; Glucose Intolerance; Liver; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Ovariectomy; Overweight; Phytoestrogens; Raloxifene Hydrochloride; Random Allocation; Selective Estrogen Receptor Modulators | 2015 |